  CommentaryConflicts of interest in translational researchMalcolm R Parks1  and Mary L Disis2  1Office of Research, University of Washington, Seattle, WA, USA 2Tumor Vaccine Group, University of Washington, Seattle, WA, USA  author email corresponding author email
Journal of Translational Medicine 2004,
2:28doi:10.1186/1479-5876-2-28 Abstract
Translational research requires a team approach to scientific inquiry and product development. Translational research teams consist of basic and clinical scientists who can be members of both academic and industrial communities. The conception, pre-clinical testing, and clinical evaluation of a diagnostic or therapeutic approach demands an intense interaction between investigators with diverse backgrounds. As the barriers between industry and academia are removed, issues of potential conflict of interest become more complex. Translational researchers must become aware of the situations which constitute conflict of interest and understand how such conflicts can impact their research programs. Finally, the translational research community must participate in the dialogue ongoing in the public and private sectors and help shape the rules that will govern conflicts that arise during the evolution of their research programs. | 
on Google Scholar
